This risk seems to be greater in
elderly patients on high-dose therapy, especially females. The
symptoms are persistent and in some patients appear to be irreversible.
All antipsychotic agents should be discontinued if tardive dyskinesia develops. Should it be necessary to reinstitute treatment, increase the dosage of the agent, or switch to a different antipsychotic agent, the syndrome may be masked.